| 14/0203/15-S |
4306B |
Spiolto Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 3x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| 14/0203/15-S |
4305B |
Spiolto Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 2x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| 14/0203/15-S |
4304B |
Spiolto Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 1x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| 14/0204/15-S |
4311B |
Yanimo Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 8x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| 14/0204/15-S |
4310B |
Yanimo Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 3x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| 14/0204/15-S |
4309B |
Yanimo Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 2x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| 14/0204/15-S |
4308B |
Yanimo Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 1x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| 14/0203/15-S |
4307B |
Spiolto Respimat 2,5 mikrogramu/2,5 mikrogramu inhala?ný roztok |
sol ihl 8x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
16.06.2020 |
| 14/0444/15-S |
6754B |
Srivasso 18 mikrogramov |
plv icd 5x(60x18 µg) (blis.Al/PVC/Al-nem.bal.) |
BOE |
26.11.2020 |
| 14/0444/15-S |
6753B |
Srivasso 18 mikrogramov |
plv icd 5x(30x18 µg) (blis.Al/PVC/Al+inhalátor-nem.bal.) |
BOE |
26.11.2020 |
| 14/0444/15-S |
6752B |
Srivasso 18 mikrogramov |
plv icd 3x(10x18 µg) (blis.Al/PVC/Al+inhalátor) |
BOE |
26.11.2020 |
| 14/0444/15-S |
6751B |
Srivasso 18 mikrogramov |
plv icd 1x(10x18 µg) (blis.Al/PVC/Al+inhalátor) |
BOE |
26.11.2020 |
| 14/0444/15-S |
6750B |
Srivasso 18 mikrogramov |
plv icd 9x(10x18 µg) (blis.Al/PVC/Al) |
BOE |
26.11.2020 |
| 14/0444/15-S |
6749B |
Srivasso 18 mikrogramov |
plv icd 6x(10x18 µg) (blis.Al/PVC/Al) |
BOE |
26.11.2020 |
| 14/0444/15-S |
6748B |
Srivasso 18 mikrogramov |
plv icd 3x(10x18 µg) (blis.Al/PVC/Al) |
BOE |
26.11.2020 |
| 14/0394/13-S |
7579A |
Striverdi Respimat |
sol ihl 8x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
29.10.2018 |
| 14/0394/13-S |
7578A |
Striverdi Respimat |
sol ihl 3x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
29.10.2018 |
| 14/0394/13-S |
7577A |
Striverdi Respimat |
sol ihl 2x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
29.10.2018 |
| 14/0394/13-S |
7576A |
Striverdi Respimat |
sol ihl 1x(1 inh.+1 nápl?/60 vstrekov) (nápl? PE/PP) |
BOE |
29.10.2018 |
| EU/1/16/1146/018 |
1973C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 100x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/017 |
1972C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 90x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/016 |
1971C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 70x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/015 |
1970C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 60x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/014 |
1969C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 30x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/013 |
1968C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 28x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/012 |
1967C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 14x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/011 |
1965C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 10x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/010 |
1964C |
Glyxambi 25 mg/5 mg filmom obalené tablety |
tbl flm 7x1x25 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/009 |
1963C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 100x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/008 |
1962C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 90x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/007 |
1961C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 70x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/006 |
1960C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 60x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/005 |
1959C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 30x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/004 |
1958C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 28x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/003 |
1957C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 14x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/002 |
1956C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 10x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/16/1146/001 |
1955C |
Glyxambi 10 mg/5 mg filmom obalené tablety |
tbl flm 7x1x10 mg/5 mg (blis.PVC/PVDC/Al-jednotl.dávka) |
BOE |
11.11.2021 |
| EU/1/15/1003/040 |
0931C |
Synjardy 12,5 mg/1000 mg filmom obalené tablety |
tbl flm 90x1x12,5 mg/1000 mg (blis.PVC/PVDC/Al-perf.) |
BOE |
27.05.2020 |
| EU/1/15/1003/039 |
0930C |
Synjardy 12,5 mg/850 mg filmom obalené tablety |
tbl flm 90x1x12,5 mg/850 mg (blis.PVC/PVDC/Al-perf.) |
BOE |
27.05.2020 |
| EU/1/15/1003/038 |
0929C |
Synjardy 5 mg/1000 mg filmom obalené tablety |
tbl flm 90x1x5 mg/1000 mg (blis.PVC/PVDC/Al-perf.) |
BOE |
27.05.2020 |
| EU/1/15/1003/037 |
0928C |
Synjardy 5 mg/850 mg filmom obalené tablety |
tbl flm 90x1x5 mg/850 mg (blis.PVC/PVDC/Al-perf.) |
BOE |
27.05.2020 |
| EU/1/15/1056/001 |
7080B |
Praxbind 2,5 g/50 ml injek?ný/infúzny roztok |
sol ijf 2x50 ml/2,5 g (liek.inj.skl) |
BOE |
20.11.2020 |
| EU/1/14/954/004 |
3136B |
Vargatef 150 mg mäkké kapsuly |
cps mol 60x150 mg (blis.Al/Al) |
BOE |
21.11.2019 |
| EU/1/14/954/003 |
3135B |
Vargatef 100 mg mäkké kapsuly |
cps mol 120(60x2)x100 mg (blis.Al/Al) |
BOE |
21.11.2019 |
| EU/1/14/954/002 |
3134B |
Vargatef 100 mg mäkké kapsuly |
cps mol 120x100 mg (blis.Al/Al) |
BOE |
21.11.2019 |
| EU/1/14/954/001 |
3133B |
Vargatef 100 mg mäkké kapsuly |
cps mol 60x100 mg (blis.Al/Al) |
BOE |
21.11.2019 |
| EU/1/14/979/004 |
3085B |
Ofev 150 mg mäkké kapsuly |
cps mol 60x1x150 mg (blis.Al/Al-perf.) |
BOE |
15.01.2020 |
| EU/1/14/979/003 |
3084B |
Ofev 150 mg mäkké kapsuly |
cps mol 30x1x150 mg (blis.Al/Al-perf.) |
BOE |
15.01.2020 |
| EU/1/14/979/002 |
3083B |
Ofev 100 mg mäkké kapsuly |
cps mol 60x1x100 mg (blis.Al/Al-perf.) |
BOE |
15.01.2020 |
| EU/1/14/979/001 |
3082B |
Ofev 100 mg mäkké kapsuly |
cps mol 30x1x100 mg (blis.Al/Al-perf.) |
BOE |
15.01.2020 |
1
